HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ruediger Lange Thomas Guenther Christian Schreiber Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lange, R. Articles by Schreiber, C. Search for Related Content PubMed PubMed Citation Articles by Lange, R. Articles by Schreiber, C. Related Collections Congenital - acyanotic Valve disease

J Thorac Cardiovasc Surg 2007;134:304-310
© 2007 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair

^a Department of Cardiovascular Surgery, German Heart Center, Clinic at the Technical University, Munich, Germany
^b Department of Pediatric Cardiology, German Heart Center, Clinic at the Technical University, Munich, Germany
^c Institute of Medical Statistics and Epidemiology, Technical University, Munich, Germany.

Received for publication September 21, 2006; revisions received January 2, 2007; accepted for publication January 8, 2007.

^_* Address for reprints: Thomas Günther, MD, Klinik für Herz und Gefäßchirurgie, Deutsches Herzzentrum, Klinik an der Technischen Universität München, Lazarettstraße 36, D-80636 München. (Email: Guenther{at}dhm.mhn.de).

Objective: Down syndrome is frequently associated with complete atrioventricular septal defect. The aim of this retrospective study was to evaluate the impact of Down syndrome on morphologic features, surgical management, and perioperative and long-term mortality in patients with complete atrioventricular septal defect.

Methods: Between October 1974 and March 2005, 476 patients with complete atrioventricular septal defect underwent surgery, 341 (71.6%) of whom had Down syndrome. A total of 336 patients (70.6%) underwent primary repair, 95 patients (20%) underwent palliative surgery on an average of 3.4 ± 2.9 years before repair, and 45 patients (9.4%) had no subsequent repair.

Results: Patients with Down syndrome (group D) exhibited higher preoperative pulmonary artery pressure (P = .012) and resistance (P = .006) compared with patients without Down syndrome (group ND). Rastelli types B and C were more frequent in group D (P = .002), but left atrioventricular valve anomalies were more frequent in group ND (P = .03). No difference was seen regarding operative strategy (P = .117) and timing of repair (P = .32). Thirty-day mortality after complete atrioventricular septal defect repair was 4.9% in group D compared with 5.6% in group ND. Actuarial survival after 20 years is 84% ± 2.5% (group D) and 75% ± 5.7% (group ND) (P = .252), and freedom from left atrioventricular valve-related reoperation is 82% ± 2.9% (group D) and 72% ± 5.3% (group ND) (P = .004). Reinterventions on the left atrioventricular valve were required significantly more often in patients in group ND.

Conclusions: The presence of Down syndrome in patients with complete atrioventricular septal defect is not a risk factor for surgical repair. Because of the early development of pulmonary vascular disease, primary repair should be performed within the first 6 months of life. In the long term, reintervention on the left atrioventricular valve is more often required in children with a normal chromosomal pattern.

This article has been cited by other articles:

				R. Formigari, G. Michielon, M. C. Digilio, G. Piacentini, A. Carotti, A. Giardini, R. M. Di Donato, and B. Marino Genetic syndromes and congenital heart defects: how is surgical management affected? Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 606 - 614. [Abstract] [Full Text] [PDF]